GntR-like SCO3932 Protein Provides a Link between Actinomycete Integrative and Conjugative Elements and Secondary Metabolism

<i>Streptomyces</i> bacteria produce a plethora of secondary metabolites including the majority of medically important antibiotics. The onset of secondary metabolism is correlated with morphological differentiation and controlled by a complex regulatory network involving numerous regulat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Krzysztof J. Pawlik, Mateusz Zelkowski, Mateusz Biernacki, Katarzyna Litwinska, Pawel Jaworski, Magdalena Kotowska
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/688a78dd1fa849bfa29eac95b60763e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<i>Streptomyces</i> bacteria produce a plethora of secondary metabolites including the majority of medically important antibiotics. The onset of secondary metabolism is correlated with morphological differentiation and controlled by a complex regulatory network involving numerous regulatory proteins. Control over these pathways at the molecular level has a medical and industrial importance. Here we describe a GntR-like DNA binding transcription factor SCO3932, encoded within an actinomycete integrative and conjugative element, which is involved in the secondary metabolite biosynthesis regulation. Affinity chromatography, electrophoresis mobility shift assay, footprinting and chromatin immunoprecipitation experiments revealed, both in vitro and in vivo, SCO3932 binding capability to its own promoter region shared with the neighboring gene <i>SCO3933</i>, as well as promoters of polyketide metabolite genes, such as <i>cpkD</i>, a coelimycin biosynthetic gene, and <i>actII-orf4</i>—an activator of actinorhodin biosynthesis. Increased activity of SCO3932 target promoters, as a result of SCO3932 overproduction, indicates an activatory role of this protein in <i>Streptomyces coelicolor</i> A3(2) metabolite synthesis pathways.